BACKGROUND: Although the consensus is that gender does not influence HIV progression, its relevance may depend on the setting. AIM: To study gender differences in HIV progression to AIDS and death from 1986 to 2001 in a cohort of injecting drug user (IDU) seroconverters in Spain. METHODS: Risk of AIDS and death in persons infected for the same length of time were compared through Kaplan-Meier, allowing for late entry, and Cox regression adjusting for gender, age, and calendar period (before 1992, 1992-1995, 1996-1998, 1999-2001) fitted as time dependent covariates. RESULTS: Of 929 IDU, 24.7% were women. Median seroconversion year was 1993.3 for men and women. 44% of women and 34% of men received antiretroviral therapy. Risk of AIDS was lower in women in univariate (hazard ratio (HR) 0.72; 95%CI:0.51 to 1.01) and multivariate analyses (HR 0.73 95%CI:0.52 to 1.03). A 46% reduction in risk of AIDS for period 1999-2001 compared with 1992-1995 was seen in both men and women (HR: 0.56 (95%CI:0.36 to 0.87). As for mortality, women's risk of death was lower univariately (HR 0.67 95%CI:0.45 to 0.99) although compared with 1992-95, men experienced a 34% reduction in mortality during 1999-2001 (HR 0.66 95%CI:0.40 to 1.01), which was not statistically significant in women. CONCLUSIONS: HIV progression was lower in female IDU before and after 1997 and their uptake of antiretroviral therapy was higher than male IDU. The inability to detect a reduction in mortality for women during 1999-2001 is probably attributable to lack of power. Differences in severity of addiction, drug using patterns, and competing causes of death may explain these findings.
BACKGROUND: Although the consensus is that gender does not influence HIV progression, its relevance may depend on the setting. AIM: To study gender differences in HIV progression to AIDS and death from 1986 to 2001 in a cohort of injecting drug user (IDU) seroconverters in Spain. METHODS: Risk of AIDS and death in persons infected for the same length of time were compared through Kaplan-Meier, allowing for late entry, and Cox regression adjusting for gender, age, and calendar period (before 1992, 1992-1995, 1996-1998, 1999-2001) fitted as time dependent covariates. RESULTS: Of 929 IDU, 24.7% were women. Median seroconversion year was 1993.3 for men and women. 44% of women and 34% of men received antiretroviral therapy. Risk of AIDS was lower in women in univariate (hazard ratio (HR) 0.72; 95%CI:0.51 to 1.01) and multivariate analyses (HR 0.73 95%CI:0.52 to 1.03). A 46% reduction in risk of AIDS for period 1999-2001 compared with 1992-1995 was seen in both men and women (HR: 0.56 (95%CI:0.36 to 0.87). As for mortality, women's risk of death was lower univariately (HR 0.67 95%CI:0.45 to 0.99) although compared with 1992-95, men experienced a 34% reduction in mortality during 1999-2001 (HR 0.66 95%CI:0.40 to 1.01), which was not statistically significant in women. CONCLUSIONS: HIV progression was lower in female IDU before and after 1997 and their uptake of antiretroviral therapy was higher than male IDU. The inability to detect a reduction in mortality for women during 1999-2001 is probably attributable to lack of power. Differences in severity of addiction, drug using patterns, and competing causes of death may explain these findings.
Authors: S J Gange; Y Barrón; R M Greenblatt; K Anastos; H Minkoff; M Young; A Kovacs; M Cohen; W A Meyer; A Muñoz Journal: J Epidemiol Community Health Date: 2002-02 Impact factor: 3.710
Authors: Antonia L Moore; Caroline A Sabin; Margaret A Johnson; Andrew N Phillips Journal: J Acquir Immune Defic Syndr Date: 2002-02-01 Impact factor: 3.731
Authors: A Mocroft; R Brettle; O Kirk; A Blaxhult; J M Parkin; F Antunes; P Francioli; A D'Arminio Monforte; Z Fox; J D Lundgren Journal: AIDS Date: 2002-08-16 Impact factor: 4.177
Authors: Mardge H Cohen; Audrey L French; Lorie Benning; Andrea Kovacs; Kathryn Anastos; Mary Young; Howard Minkoff; Nancy A Hessol Journal: Am J Med Date: 2002-08-01 Impact factor: 4.965
Authors: Monica Gandhi; Peter Bacchetti; Paolo Miotti; Thomas C Quinn; Fulvia Veronese; Ruth M Greenblatt Journal: Clin Infect Dis Date: 2002-07-02 Impact factor: 9.079
Authors: J del Amo; J del Romero; A Barrasa; S Pérez-Hoyos; C Rodríguez; M Díez; S García; V Soriano; J Castilla Journal: Sex Transm Infect Date: 2002-08 Impact factor: 3.519
Authors: Gerald N DeLorenze; Constance Weisner; Ai-Lin Tsai; Derek D Satre; Charles P Quesenberry Journal: Alcohol Clin Exp Res Date: 2010-11-08 Impact factor: 3.455
Authors: Michael-John S Milloy; Brandon D L Marshall; Thomas Kerr; Jane Buxton; Tim Rhodes; Julio Montaner; Evan Wood Journal: AIDS Date: 2012-06-01 Impact factor: 4.177
Authors: Vlada V Melekhin; Bryan E Shepherd; Samuel E Stinnette; Peter F Rebeiro; Megan M Turner; Timothy R Sterling Journal: PLoS One Date: 2012-09-13 Impact factor: 3.240
Authors: Martha L Carvour; Jerald P Harms; Charles F Lynch; Randall R Mayer; Jeffery L Meier; Dawei Liu; James C Torner Journal: PLoS One Date: 2015-06-24 Impact factor: 3.240
Authors: Anne Guionnet; Bárbara Navaza; Belén Pizarro de la Fuente; María Jesús Pérez-Elías; Fernando Dronda; Rogelio López-Vélez; José A Pérez-Molina Journal: BMC Public Health Date: 2014-10-29 Impact factor: 3.295
Authors: Simbarashe Takuva; Mhairi Maskew; Alana T Brennan; Lawrence Long; Ian Sanne; Matthew P Fox Journal: J Int AIDS Soc Date: 2014-03-03 Impact factor: 5.396